Novotech Health Holdings is a leading Asian biotech CRO & consists of two operating brands, Novotech and PPC. Novotech Holdings is full-service CRO with integrated labs & phase I facilities providing drug development consulting & clinical development services. It has been instrumental in the success of approximately 3,700 clinical trials across all trial phases and therapeutic areas. Novotech is uniquely positioned to serve biopharmaceutical clients conducting clinical trials in Asia & globally.